Welcome to our dedicated page for CTST news (Ticker: CTST), a resource for investors and traders seeking the latest updates and insights on CTST stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CTST's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CTST's position in the market.
CannTrust Holdings announced the appointment of Greg Guyatt and Dan Hogan as new directors, expanding its Board to six members. Guyatt, who has been CEO since February 2020, brings extensive finance experience, and Hogan offers valuable insights from over 40 years in consumer products. The Company remains under CCAA protection while it seeks to resolve civil litigation and explore financing options amidst an uncertain timeline for its strategy review. CannTrust aims to restore its cannabis licenses and operations in the Canadian market.
CannTrust Holdings announced the resignation of Mark Litwin from its board and Stan Abramowitz as Secretary. David Blair has been appointed as the new Secretary. The company is under CCAA protection to resolve civil litigation claims and explore financing options while attempting to restore its cannabis licenses and operations. The ongoing efforts are confidential with uncertain outcomes. CannTrust remains focused on rebuilding its business in the Canadian recreational and medical cannabis markets.
CannTrust Holdings has received a CCAA Representation Order from the Ontario Superior Court of Justice as part of its restructuring efforts under the Companies' Creditors Arrangement Act (CCAA). This order appoints representatives for Canadian and U.S. Securities Claimants and extends the stay of proceedings to April 30, 2021. The court also appointed Ernst & Young Inc. as the monitor for these proceedings. CannTrust aims to negotiate settlements regarding Securities Claims as part of their restructuring plan.
CannTrust Holdings Inc. re-enters the Canadian medical cannabis market with its new brand estora™, offering products like oil drops, capsules, and dried flowers. Available via their new ecommerce platform, estoramedical.com, the brand aims to enhance patient care through quality products and educational resources. CEO Greg Guyatt emphasized the focus on evolving to meet patient needs. Despite the launch, CannTrust remains under CCAA protection as it addresses legal claims and strategic alternatives.
CannTrust Holdings Inc. has announced its return to the Canadian cannabis market with the launch of its recreational brands, LiivTM and Synr.gTM. Products will be available starting December 2020, with plans to expand the product line in early 2021. CEO Greg Guyatt expressed optimism regarding the company's evolution and commitment to quality products. However, CannTrust remains under CCAA protection, facing ongoing legal and financial challenges, including significant workforce reductions and a lack of meaningful revenue.
CannTrust announced that the Ontario Superior Court of Justice has extended the deadline for the Company to hold its next annual shareholder meeting by 120 days post-CCAA proceedings. The Company remains in ongoing CCAA proceedings, pending the resolution of its financial situation, which includes contingent liabilities and potential regulatory investigations. CannTrust aims to resume manufacturing operations with its cannabis products expected to be available in Canadian markets by Q4 2020. However, the company is currently subject to a cease-trade order due to previous failure to meet disclosure obligations.
CannTrust Holdings Inc. announced plans to request an extension for its next annual shareholder meeting, currently under the Companies' Creditors Arrangement Act (CCAA). The motion will be heard by the Ontario Superior Court on September 16, 2020. This extension seeks to push the meeting to 120 days after CCAA proceedings conclude. CannTrust will file necessary court materials, including an affidavit and a draft order, on September 9, 2020. The company warns that forward-looking statements may face risks that could lead to significant uncertainties regarding its recovery and obligations to creditors.
CannTrust Holdings has announced the reinstatement of its licenses for the Vaughan Manufacturing Facility as of August 6, 2020. This decision follows the company's year-long efforts to address regulatory deficiencies. Manufacturing operations are expected to restart immediately, with cannabis products anticipated to be available in Q4 2020. The CEO emphasized significant improvements in regulatory compliance, while the company remains under CCAA protection to resolve civil litigation issues and strategic alternatives. CannTrust continues to face challenges, including a cease-trade order from the Ontario Securities Commission.
